UNSPSC 51282108: Faropenem

This classification denotes a beta-lactam antibiotic with the molecular formula C12H15NO5S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, F52Y83BGH3 chemically known as 4-thia-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid, 6-((1r)-1-hydroxyethyl)-7-oxo-3-((2r)-tetrahydro-2-furanyl)-,(5r,6s) but generally known as faropenem, which bears US NIH Compound Identifier 3333. European Medicines Agency schedules Faropenem in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07512MIG.

UNSPSC 51282108 Faropenem, a Commodity code, nominally designates a specific beta-lactam antibiotic, but recent state and local procurement activity under this code shows minimal direct purchasing of the named pharmaceutical and instead reflects broader solicitation of medical supplies, pharmaceuticals, and pharmacy program infrastructure. State and local governments using this code are procuring naloxone and drug deactivation systems for community health initiatives, generic multi-source pharmaceuticals and over-the-counter products through cooperative purchasing alliances, emergency medical supplies for fire rescue operations, and direct-to-manufacturer prescription fulfillment capabilities. Issuing bodies include county health departments, state health and human services commissions administering cooperative purchasing vehicles, municipal fire departments, and multistate purchasing alliances serving multiple participating jurisdictions. The fragmented nature of recent opportunities—spanning naloxone procurement, generic pharmaceutical frameworks, emergency medical supplies, and pharmacy benefit innovation—suggests the code captures commodity-level pharmaceutical and medical-supply procurement rather than a single therapeutic agent.

Recent activity appears concentrated in Florida and Minnesota, with Texas representing emerging interest in pharmacy program innovation. Seminole County, Florida issued IFB 60459723LAS in June 2026 seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries and a response deadline of July 26, 2023 (note: date inconsistency in source). The City of Tampa posted IFB 26P00145 in March 2026 for 169 line items of emergency medical and first aid supplies for the Tampa Fire Department Rescue Division, designated as a sheltered market opportunity for certified Small Local Business Enterprises with an estimated contract value of $700,000.00. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration, issued RFP S1070000015802 in January 2026 for generic multi-source pharmaceuticals and OTC products, with proposals due March 26, 2026, serving multiple state and local government facilities including Oregon. The Texas Health and Human Services Commission posted RFI HHS0017013 in April 2026 to gather vendor information on direct-to-manufacturer prescription programs. The mismatch between the code's nominal scope and actual procurement activity suggests limited purchasing of faropenem specifically under this code in current state and local markets.